logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5127.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5127.produseast1
12-month post-treatment outcomes of previously treated drug-resistant tuberculosis patients subsequently treated with concomitant bedaquiline and delamanid +/-carbapenem, in Mumbai, India | Conference Material / Poster | MSF Science Portal
Conference Material
|Poster

12-month post-treatment outcomes of previously treated drug-resistant tuberculosis patients subsequently treated with concomitant bedaquiline and delamanid +/-carbapenem, in Mumbai, India

Chavan V, Silsarma A, Khan S, Singh P, Iyer A, Mahajan R, Dalal A, Spencer H, Isaakidis P
Download

Similar Content
Video
|Video
12-month post-treatment outcomes of previously treated drug-resistant tuberculosis patients subsequently treated with concomitant bedaquiline and delaminid +/- carbapenem, in Mumbai, India
2024 October 24 • MSF Scientific Days Asia 2024
Loading...
Loading...
No abstract available

Countries

India

Subject Area

tuberculosis

Languages

English
Published Date
08 Nov 2024
Conference
MSF Scientific Days Asia 2024
Linked Content
Conference Material
|Video
12-month post-treatment outcomes of previously treated drug-resistant tuberculosis patients subsequently treated with concomitant bedaquiline and delaminid +/- carbapenem, in Mumbai, India
2024 October 24 • MSF Scientific Days Asia 2024